These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11318225)

  • 1. Mixed effects models with censored data with application to HIV RNA levels.
    Hughes JP
    Biometrics; 1999 Jun; 55(2):625-9. PubMed ID: 11318225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling HIV-RNA viral load in vertically infected children.
    Gray L; Cortina-Borja M; Newell ML
    Stat Med; 2004 Mar; 23(5):769-81. PubMed ID: 14981674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximum likelihood inference for left-censored HIV RNA data.
    Lynn HS
    Stat Med; 2001 Jan; 20(1):33-45. PubMed ID: 11135346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalized linear mixed model for binary outcomes when covariates are subject to measurement errors and detection limits.
    Xie X; Xue X; Strickler HD
    Stat Med; 2018 Jan; 37(1):119-136. PubMed ID: 28980332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flexible longitudinal linear mixed models for multiple censored responses data.
    Lachos VH; A Matos L; Castro LM; Chen MH
    Stat Med; 2019 Mar; 38(6):1074-1102. PubMed ID: 30421470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative investigation of methods for longitudinal data with limits of detection through a case study.
    Fu P; Hughes J; Zeng G; Hanook S; Orem J; Mwanda OW; Remick SC
    Stat Methods Med Res; 2016 Feb; 25(1):153-66. PubMed ID: 22504231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed models for longitudinal left-censored repeated measures.
    Thiébaut R; Jacqmin-Gadda H
    Comput Methods Programs Biomed; 2004 Jun; 74(3):255-60. PubMed ID: 15135576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian semiparametric modeling for HIV longitudinal data with censoring and skewness.
    Castro LM; Wang WL; Lachos VH; Inácio de Carvalho V; Bayes CL
    Stat Methods Med Res; 2019 May; 28(5):1457-1476. PubMed ID: 29551086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches for censored longitudinal data in joint modelling of longitudinal and survival data, with application to HIV vaccine studies.
    Yu T; Wu L; Gilbert P
    Lifetime Data Anal; 2019 Apr; 25(2):229-258. PubMed ID: 29948579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the use of magnitude of reduction in HIV-1 RNA in clinical trials: statistical analysis and potential biases.
    Flandre P; Durier C; Descamps D; Launay O; Joly V
    J Acquir Immune Defic Syndr; 2002 May; 30(1):59-64. PubMed ID: 12048363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of multistage pooling studies of biological specimens for estimating disease incidence and prevalence.
    Brookmeyer R
    Biometrics; 1999 Jun; 55(2):608-12. PubMed ID: 11318222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases.
    Marschner IC; Betensky RA; DeGruttola V; Hammer SM; Kuritzkes DR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):220-7. PubMed ID: 10077169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of interval-censored data from circular migrant and non-migrant sexual partnerships using the EM algorithm.
    Zuma K; Lurie M; Jorgensen M
    Stat Med; 2007 Jan; 26(2):309-19. PubMed ID: 16538697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed-model analysis of a censored normal distribution with reference to animal breeding.
    Carriquiry AL; Gianola D; Fernando RL
    Biometrics; 1987 Dec; 43(4):929-39. PubMed ID: 3509964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation and inference on correlations between biomarkers with repeated measures and left-censoring due to minimum detection levels.
    Xie X; Xue X; Gange SJ; Strickler HD; Kim MY;
    Stat Med; 2012 Sep; 31(21):2275-89. PubMed ID: 22714546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating and comparing reduction in HIV-1 RNA in clinical trials using methods for interval censored data.
    Flandre P; Alcais A; Descamps D; Morand-Joubert L; Joly V
    J Acquir Immune Defic Syndr; 2004 Mar; 35(3):286-92. PubMed ID: 15076244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate-$t$ nonlinear mixed models with application to censored multi-outcome AIDS studies.
    Lin TI; Wang WL
    Biostatistics; 2017 Oct; 18(4):666-681. PubMed ID: 28369172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivariate longitudinal model for the analysis of the evolution of HIV RNA and CD4 cell count in HIV infection taking into account left censoring of HIV RNA measures.
    Thiébaut R; Jacqmin-Gadda H; Leport C; Katlama C; Costagliola D; Le Moing V; Morlat P; Chêne G;
    J Biopharm Stat; 2003 May; 13(2):271-82. PubMed ID: 12729394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical methods for HIV dynamic studies in AIDS clinical trials.
    Wu H
    Stat Methods Med Res; 2005 Apr; 14(2):171-92. PubMed ID: 15807150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian Two-Part Tobit Models with Left-Censoring, Skewness, and Nonignorable Missingness.
    Dagne GA; Huang Y
    J Biopharm Stat; 2015; 25(4):714-30. PubMed ID: 24905924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.